Laboratory Tests for Diabetic Ketoacidosis (DKA) Management
Essential laboratory tests for DKA management include blood glucose, serum ketones, electrolytes, arterial/venous pH, bicarbonate, BUN, creatinine, and complete blood count, which should be monitored every 2-4 hours during initial treatment to guide therapy and prevent complications. 1
Initial Diagnostic Tests
- Blood glucose: Though hyperglycemia (>250 mg/dL) is common, euglycemic DKA can occur, especially with SGLT2 inhibitor use 2
- Serum ketones: Preferred over urine ketones for diagnosis and monitoring 2
- Arterial or venous pH: For assessing acidosis severity (mild: 7.25-7.30, moderate: 7.00-7.24, severe: <7.00) 1
- Serum bicarbonate: To evaluate acidosis (mild: 15-18 mEq/L, moderate: 10-14 mEq/L, severe: <10 mEq/L) 1
- Anion gap: Typically >10 mEq/L in DKA 2
- Electrolytes: Particularly potassium, sodium, chloride, and phosphate 1
- BUN and creatinine: To assess renal function and dehydration 1
- Complete blood count with differential: To evaluate for infection 2
- A1C: To assess long-term glycemic control 2
- Calculated serum osmolality: To differentiate DKA from hyperosmolar hyperglycemic state 1
Monitoring Tests During Treatment
- Blood glucose: Monitor hourly until stable, then every 2-4 hours 1
- Electrolytes, particularly potassium: Every 2-4 hours initially 1
- Corrected sodium: Calculate for each 100 mg/dL glucose >100 mg/dL, add 1.6 mEq to sodium value 1
- Arterial or venous pH: Every 2-4 hours until resolution 1
- Serum bicarbonate: Every 2-4 hours until resolution 1
- Anion gap: To track resolution of ketoacidosis 1
Additional Tests to Consider
- Urinalysis: To evaluate for infection 2
- Blood and urine cultures: If infection is suspected 2
- Electrocardiogram: To assess for cardiac abnormalities, especially with electrolyte disturbances 2
- Amylase and lipase: If pancreatitis is suspected 2
- Hepatic transaminases: To evaluate liver function 2
- Troponin: If cardiac ischemia is suspected 2
- Chest radiography: If respiratory infection is suspected 2
Resolution Criteria Monitoring
Monitor laboratory values until the following resolution criteria are met:
- Glucose: <200 mg/dL
- Serum bicarbonate: ≥18 mEq/L
- Venous pH: >7.3 1
Common Pitfalls and Caveats
Overlooking euglycemic DKA: Don't rule out DKA based solely on normal blood glucose, especially in patients taking SGLT2 inhibitors 2, 3
Inadequate potassium monitoring: Insulin therapy drives potassium intracellularly, potentially causing dangerous hypokalemia. Ensure serum potassium is >3.3 mEq/L before starting insulin 1, 4
Missing underlying causes: Always investigate for precipitating factors such as infection, myocardial infarction, stroke, or medication non-adherence 5
Premature discontinuation of IV insulin: Continue insulin until ketoacidosis resolves (not just until blood glucose normalizes) 1
Inadequate transition to subcutaneous insulin: Administer basal insulin 2-4 hours before stopping IV insulin to prevent rebound ketoacidosis 5, 1
Overlooking cerebral edema risk: Monitor neurological status hourly, especially in younger patients 1
Bicarbonate administration: Generally not recommended for routine DKA management 1
By following these laboratory monitoring guidelines, clinicians can effectively manage DKA while minimizing complications and improving outcomes.